<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75-ijms-21-03544">
 <label>75.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huwiler</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Zangemeister-Wittke</surname>
    <given-names>U.</given-names>
   </name>
  </person-group>
  <article-title>The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives</article-title>
  <source>Pharmacol. Ther.</source>
  <year>2018</year>
  <volume>185</volume>
  <fpage>34</fpage>
  <lpage>49</lpage>
  <pub-id pub-id-type="doi">10.1016/j.pharmthera.2017.11.001</pub-id>
  <pub-id pub-id-type="pmid">29127024</pub-id>
 </element-citation>
</ref>
